Cited by 66Growth Hormone and Insulin-like Growth FactorsBone health and osteoporosis researchHormonal and reproductive studies

Fracture Incidence in GH-Deficient Patients on Complete Hormone Replacement Including GH

Holmer, Helene, Svensson, Johan, Rylander, Lars, Johannsson, Gudmundur, Rosén, Thord, Bengtsson, Bengt-Åke, Thorén, Marja, Höybye, Charlotte +8 more·2007·Journal of Bone and Mineral Research

Abstract

Fracture risk in GHD patients is not definitely established. Studying fracture incidence in 832 patients on GH therapy and 2581 matched population controls, we recorded a doubled fracture risk in CO GHD women, but a significantly lower fracture risk in AO GHD men. Introduction: The objective of this study was to evaluate fracture incidence in patients with confirmed growth hormone deficiency (GHD) on replacement therapy (including growth hormone [GH]) compared with population controls, while also taking potential confounders and effect modifiers into account. Materials and Methods: Eight hundred thirty-two patients with GHD and 2581 matched population controls answered a questionnaire about fractures and other background information. Incidence rate ratio (IRR) and 95% CI for first fracture were estimated. The median time on GH therapy for childhood onset (CO) GHD men and women was 15 and 12 yr, respectively, and 6 and 5 yr for adult onset (AO) GHD men and women, respectively. Results: A more than doubled risk (IRR, 2.29; 95% CI, 1.23–4.28) for nonosteoporotic fractures was recorded in women with CO GHD, whereas no risk increase was observed among CO GHD men (IRR, 0.61) and AO GHD women (IRR, 1.08). A significantly decreased incidence of fractures (IRR, 0.54; 95% CI, 0.34–0.86) was recorded in AO GHD men. Conclusions: Increased fracture risk in CO GHD women can most likely be explained by interaction between oral estrogen and the GH–IGF-I axis. The adequate substitution rate of testosterone (90%) and GH (94%) may have resulted in significantly lower fracture risk in AO GHD men.

Integrity signals

Registry

Crossref · 10.1359/jbmr.070811

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with isolated GH deficiency and with multiple pituitary deficiencies usually have low BMD.

    “Patients with isolated GH deficiency (GHD) and with multiple pituitary deficiencies usually have low BMD.”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [44]

  • GH may play a role in the achievement of peak bone mass.

    “which may present the potential role of GH in the achievement of peak bone mass [44–49].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [44]

  • GHD itself is crucial for the development of osteopenia in hypopituitary patients.

    “Studies have shown that GHD itself is crucial for the development of osteopenia in hypopituitary patients [44, 49, 51].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [44]

  • GHD and hypopituitarism are associated with increased fracture risk.

    “It has been reported that GHD and hypopituitarism are associated with increased fracture risk [17, 44, 51, 55].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [44]

  • In patients with childhood onset GHD, there is a clear reduction in BMD.

    “In patients with childhood onset (CO) GHD there seems to be a clear reduction in BMD, which may present the potential role of GH in the achievement of peak bone mass [44–49].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [44]

Cites

Flagged first, then by citations

3 of the 44 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Holmer, H., Svensson, J., Rylander, L., Johannsson, G., Rosén, T., Bengtsson, B.-Å., Thorén, M., Höybye, C., Degerblad, M., Bramnert, M., Hägg, E., Engström, B. E., Ekman, B., Thorngren, K.-G., Hagmar, L., & Erfurth, E.-M.
Affiliations
  • Skåne University Hospital (SE)
  • Sahlgrenska University Hospital (SE)
  • Lund University (SE)
  • Karolinska University Hospital (SE)
  • Department of Endocrinology, University Hospital, Malmö, Sweden
  • University Hospital of Umeå (SE)
  • Uppsala University Hospital (SE)
  • Linköping University Hospital (SE)
Corresponding author
Erfurth, Eva-Marie
Venue
Journal of Bone and Mineral Research
Published
2007-12-01
Volume
22
Issue
12
Pages
1842-1850
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2037472576
Cited by
66
References
44
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 4 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 4
FWCI
2.68
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Bone and Mineral Research (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Pfizer
  • Vetenskapsrådet
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
growth hormone deficiency, fracture risk, growth hormone therapy, hormone replacement therapy, childhood-onset growth hormone deficiency, adult-onset growth hormone deficiency, sex differences, oral estrogen, IGF-I axis
MeSH terms
Adolescent, Adult, Child, Female, Humans, Hypopituitarism, Male, Risk Factors, Sex Factors, Sweden, Testosterone, Incidence, Human Growth Hormone, Hormone Replacement Therapy, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review